Chicago Rivet & Machine (AMEX:CVR) reported quarterly earnings of $0.16 per share. This is a 51.52 percent decrease over earnings of $0.33 per share from the same period last year.
Amgen Stock Adds Good Weight After CEO’s Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate
MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1.
